MXPA03005169A - Matriz lipidica auto-emulsificante. - Google Patents

Matriz lipidica auto-emulsificante.

Info

Publication number
MXPA03005169A
MXPA03005169A MXPA03005169A MXPA03005169A MXPA03005169A MX PA03005169 A MXPA03005169 A MX PA03005169A MX PA03005169 A MXPA03005169 A MX PA03005169A MX PA03005169 A MXPA03005169 A MX PA03005169A MX PA03005169 A MXPA03005169 A MX PA03005169A
Authority
MX
Mexico
Prior art keywords
selm
lipid matrix
self emulsifying
emulsifying lipid
self
Prior art date
Application number
MXPA03005169A
Other languages
English (en)
Inventor
Kuentz Martin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA03005169A publication Critical patent/MXPA03005169A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA03005169A 2000-12-14 2001-12-08 Matriz lipidica auto-emulsificante. MXPA03005169A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00127414 2000-12-14
PCT/EP2001/014437 WO2002047663A1 (en) 2000-12-14 2001-12-08 Self emulsifying lipid matrix (selm)

Publications (1)

Publication Number Publication Date
MXPA03005169A true MXPA03005169A (es) 2003-09-22

Family

ID=8170664

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005169A MXPA03005169A (es) 2000-12-14 2001-12-08 Matriz lipidica auto-emulsificante.

Country Status (17)

Country Link
US (1) US6719996B2 (es)
EP (1) EP1349541B1 (es)
JP (1) JP4116436B2 (es)
KR (1) KR100602299B1 (es)
CN (1) CN1263446C (es)
AR (1) AR032783A1 (es)
AT (1) ATE341311T1 (es)
AU (2) AU2002216085B8 (es)
BR (1) BRPI0116121B8 (es)
CA (1) CA2431397C (es)
DE (1) DE60123661T2 (es)
DK (1) DK1349541T3 (es)
ES (1) ES2272408T3 (es)
MX (1) MXPA03005169A (es)
PT (1) PT1349541E (es)
WO (1) WO2002047663A1 (es)
ZA (1) ZA200304263B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
CN1984891B (zh) 2004-07-06 2012-08-08 弗·哈夫曼-拉罗切有限公司 用作合成nk-1受体拮抗剂的中间体的甲酰胺吡啶衍生物的制备方法
BRPI0606187A2 (pt) 2005-02-25 2009-06-09 Hoffmann La Roche comprimidos com capacidade de dispersão da substáncia do fármaco melhorada
CN101346128B (zh) * 2005-10-25 2013-10-02 雅培制药有限公司 包含低水溶解度药物的配方及其使用方法
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
ES2559475T3 (es) 2009-11-18 2016-02-12 Helsinn Healthcare Sa Composiciones para tratar náuseas y vómitos de origen central
CN106974912A (zh) 2011-10-18 2017-07-25 赫尔辛医疗股份公司 奈妥匹坦和帕洛诺司琼的治疗性组合
US8426450B1 (en) 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
WO2016136806A1 (ja) * 2015-02-26 2016-09-01 日清オイリオグループ株式会社 チョコレート用粉末油脂組成物
EP4019018A1 (en) 2015-09-11 2022-06-29 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
EP3609495A4 (en) 2017-04-10 2020-12-02 Chase Therapeutics Corporation NK1 ANTAGONIST COMBINATION AND METHOD OF TREATMENT OF SYNUCLEINOPATHIA
KR20200026920A (ko) 2017-06-30 2020-03-11 체이스 테라퓨틱스 코포레이션 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
CN109200018A (zh) * 2017-07-04 2019-01-15 南京诺瑞特医药科技有限公司 含有奈妥吡坦的微乳制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
SE1035115T5 (sv) * 1999-02-24 2015-08-04 Hoffmann La Roche 4-fenylpyridin-derivat och deras anvaendning som NK-1 receptor-antagonister
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
AU1608502A (en) 2002-06-24
AU2002216085B2 (en) 2005-11-03
KR100602299B1 (ko) 2006-07-14
CA2431397A1 (en) 2002-06-20
EP1349541A1 (en) 2003-10-08
DK1349541T3 (da) 2007-01-08
EP1349541B1 (en) 2006-10-04
CA2431397C (en) 2007-05-01
AR032783A1 (es) 2003-11-26
DE60123661D1 (de) 2006-11-16
CN1263446C (zh) 2006-07-12
CN1514720A (zh) 2004-07-21
ES2272408T3 (es) 2007-05-01
JP2004517837A (ja) 2004-06-17
WO2002047663A1 (en) 2002-06-20
BRPI0116121B8 (pt) 2021-05-25
US20020114837A1 (en) 2002-08-22
JP4116436B2 (ja) 2008-07-09
KR20030062423A (ko) 2003-07-25
ATE341311T1 (de) 2006-10-15
PT1349541E (pt) 2007-01-31
BRPI0116121B1 (pt) 2015-07-14
ZA200304263B (en) 2004-03-26
AU2002216085B8 (en) 2006-03-02
DE60123661T2 (de) 2007-08-16
US6719996B2 (en) 2004-04-13
BR0116121A (pt) 2003-10-14

Similar Documents

Publication Publication Date Title
MXPA03005169A (es) Matriz lipidica auto-emulsificante.
MXPA03001890A (es) Poliarilcarboxamidas utiles como agentes reductores de lipidos.
HK1040060A1 (en) Sustained release ranolazine formulations.
MXPA02005950A (es) Silla.
AU2001291200A1 (en) Micro-laser
ZA200100670B (en) Jackpot system.
ZA200209792B (en) Rotating platen member.
GB0021713D0 (en) Multi-format active matrix displays
NL1008636A1 (nl) Multidisplay-monitor.
MXPA03003599A (es) Agentes antiinflamatorios.
HK1049798A1 (en) Solid lipid formulations.
HK1046476A1 (en) Jack.
GB0011332D0 (en) Self service banking
MXPA03004465A (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos.
ZA200208640B (en) Self life testing unit.
MXPA03002090A (es) °-tio-aminoacidos.
HK1046959A1 (en) Thermostat.
ZA200206403B (en) Spice crusher.
ZA200206197B (en) Lipid carrier.
HK1036548A1 (en) Character display.
ZA200102716B (en) Solid pesticidal formulation.
AU2001288632A1 (en) N-way demultiplexer
EG23084A (en) Optically active 2,5-bisaryl-delta1-pyrrolines
AU2002216451A1 (en) Thermal footwear
GB0005419D0 (en) Eco.lyna

Legal Events

Date Code Title Description
FG Grant or registration